"Currently, our team is capable of performing almost all the world’s most advanced cardiovascular interventional diagnosis and treatment technologies, striving to provide comprehensive treatment guarantees for patients with various high-risk, difficult, and complex cardiovascular diseases," said Fu Guosheng.

Minimally invasive surgery For Lung Cancer has achieved major breakthroughs. Assisted by thoracoscopy, it only requires a small incision of 3 cm. It reduces the need for blood transfusion—95% of patients do not require transfusion. The operation time is shortened to within 2 hours, and the hospital stay is reduced from two weeks to one week. It improves the radicality of the surgery, increasing the 5-year survival rate by 6% and significantly enhancing the quality of life.

At the 2025 American Society of Hematology (ASH) Annual Meeting, Senior journalist Peter Goodwin from Audio Journal of Oncology invited Professor Du Juan from Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine for an on-site interview regarding her team’s research: "FasTCAR-T (GC012F/AZD0120) targeting both BCMA and CD19 as a first-line treatment for newly diagnosed multiple myeloma (NDMM)."

After Varian launched HyperSight and it was implemented clinically, how did opinions from the frontlines change? If you ask a radiologist: "Can I use HyperSight to replace the department’s 256-slice CT for hospital-wide cardiac coronary angiography screening?" Answer: No need. Physical structure dictates high-end spiral CT’s dominance in ultimate SNR. However, in the context of tumor diagnosis, this gap is clinically imperceptible.

Early-stage, radiation-sensitive tumors: Curative radiation (goal: cure). · Need to shrink tumors preoperatively or eliminate residuals postoperatively: Adjuvant radiation (goal: prevent recurrence). · Advanced cancer with severe pain, bleeding, or compression: Palliative radiation (goal: reduce suffering). Radiation therapy is personalized. Consult doctors/medical physicists for tailored plans to avoid detours.

A turning point came after the 2024 Spring Festival—Awen sought help from the transplant team led by Director Wu Tong and Director Song Yanzhi at Beijing GoBroad Boren Hospital. Under the treatment of the expert team, she first received chemotherapy combined with targeted therapy, followed by a second HSCT. Today, more than a year has passed since the second transplantation. Awen returns to the hospital for regular re-examinations, her condition is stable, and her body is gra

In pursuit of proton therapy, Mr. C came to Guangzhou Concord Cancer Center . During examinations, abnormal thickening of his rectal wall was also discovered. Further colonoscopy and pathology results ultimately confirmed he had a second primary cancer: a rectosigmoid junction tumor.

We’re delighted to announce that MedTourChina has officially signed a Framework Strategic Cooperation Agreement with Healtra, a doctor-led healthcare cooperation. This partnership marks the beginning of a new phase of collaboration between China and the GCC region, focusing on knowledge exchange, medical coordination, and healthcare innovation.